Top 10 Most Profitable Micro Cap Stocks: KCAP, MAIN, CBMX, PW, GNI, NGT, NGPC, SNTA, BDSI, IMMU (Jul 13, 2010)

Below are the top 10 most profitable Micro Cap stocks (market cap < $300 million) for the last 12 months.

Kohlberg Capital Corp. (NASDAQ:KCAP) is the 1st most profitable stock in this segment of the market. Its net profit margin was 86.29% for the last 12 months. Its operating profit margin was 46.10% for the same period. Main Street Capital Corporation (NASDAQ:MAIN) is the 2nd most profitable stock in this segment of the market. Its net profit margin was 85.63% for the last 12 months. Its operating profit margin was 52.94% for the same period. CombiMatrix Corporation (NASDAQ:CBMX) is the 3rd most profitable stock in this segment of the market. Its net profit margin was 83.12% for the last 12 months. Its operating profit margin was 82.49% for the same period. Pittsburgh & West Virginia Railroad (AMEX:PW) is the 4th most profitable stock in this segment of the market. Its net profit margin was 82.67% for the last 12 months. Its operating profit margin was 82.67% for the same period. Great Northern Iron Ore Properties (NYSE:GNI) is the 5th most profitable stock in this segment of the market. Its net profit margin was 73.50% for the last 12 months. Its operating profit margin was 73.50% for the same period.

Eastern American Natural Gas Trust (NYSE:NGT) is the 6th most profitable stock in this segment of the market. Its net profit margin was 70.37% for the last 12 months. Its operating profit margin was 70.37% for the same period. NGP Capital Resources Company (NASDAQ:NGPC) is the 7th most profitable stock in this segment of the market. Its net profit margin was 69.98% for the last 12 months. Its operating profit margin was 35.54% for the same period. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is the 8th most profitable stock in this segment of the market. Its net profit margin was 64.89% for the last 12 months. Its operating profit margin was 65.03% for the same period. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is the 9th most profitable stock in this segment of the market. Its net profit margin was 59.44% for the last 12 months. Its operating profit margin was 64.13% for the same period. Immunomedics, Inc. (NASDAQ:IMMU) is the 10th most profitable stock in this segment of the market. Its net profit margin was 58.79% for the last 12 months. Its operating profit margin was 55.97% for the same period.